These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16675762)

  • 1. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.
    Stein MB; Cantrell CR; Sokol MC; Eaddy MT; Shah MB
    Psychiatr Serv; 2006 May; 57(5):673-80. PubMed ID: 16675762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.
    Cantrell CR; Eaddy MT; Shah MB; Regan TS; Sokol MC
    Med Care; 2006 Apr; 44(4):300-3. PubMed ID: 16565629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.
    Sheehan DV; Eaddy MT; Shah MB; Mauch RP
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S354-61. PubMed ID: 16236017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims database.
    Eaddy MT; Druss BG; Sarnes MW; Regan TS; Frankum LE
    J Manag Care Pharm; 2005 Mar; 11(2):145-50. PubMed ID: 15766321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.
    Panzer PE; Regan TS; Chiao E; Sarnes MW
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S370-9. PubMed ID: 16236019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.
    McLaughlin TP; Khandker RK; Kruzikas DT; Tummala R
    J Clin Psychiatry; 2006 Aug; 67(8):1187-93. PubMed ID: 16965195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
    Schultz J; Joish V
    Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders.
    Keene MS; Eaddy MT; Nelson WW; Sarnes MW
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S362-9. PubMed ID: 16236018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
    Wade RL; Kindermann SL; Hou Q; Thase ME
    J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociological influences on antidepressant prescribing.
    Sleath B; Shih YC
    Soc Sci Med; 2003 Mar; 56(6):1335-44. PubMed ID: 12600369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term costs of treatment for depression: impact of drug selection and guideline adherence.
    Crown WH; Treglia M; Meneades L; White A
    Value Health; 2001; 4(4):295-307. PubMed ID: 11705297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antidepressant drug adherence on comorbid medication use and resource utilization.
    Katon W; Cantrell CR; Sokol MC; Chiao E; Gdovin JM
    Arch Intern Med; 2005 Nov; 165(21):2497-503. PubMed ID: 16314547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of a medical-offset effect among patients receiving antidepressant therapy.
    Thompson D; Hylan TR; McMullen W; Romeis ME; Buesching D; Oster G
    Am J Psychiatry; 1998 Jun; 155(6):824-7. PubMed ID: 9619157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.